The MEDQOR Podcast Network

In the wake of the U.S. Supreme Court’s overturning of Roe v. Wade, there’s been a lot of focus on how it’s affecting the delivery of health care, but one area that hasn’t been as focused on is what this decision means for pre-natal testing and how labs and providers of tests need to be navigating this new landscape. In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Mitera Co-founder and CEO Saman Askari about the state of pre-natal testing and how at-home testing may be a bulwark in preserving reproductive rights and autonomy.

Show Notes

In the wake of the U.S. Supreme Court’s overturning of Roe v. Wade, there’s been a lot of focus on how it’s affecting the delivery of health care, but one area that hasn’t been as focused on is what this decision means for pre-natal testing and how labs and providers of tests need to be navigating this new landscape. In this episode of Clinical Lab Chat, Director of Business Intelligence Chris Wolski interviews Mitera Co-founder and CEO Saman Askari about the state of pre-natal testing and how at-home testing may be a bulwark in preserving reproductive rights and autonomy.

What is The MEDQOR Podcast Network?

The MEDQOR Podcast Network provides insights, reporting and analysis on MedTech Innovation across all of healthcare. We’re supported by ten leading brands in healthcare, whose chief editors will join us on a recurring basis to talk with key leaders in their industries about what’s happening now.

MEDQOR provides healthcare business intelligence to help MedTech and Pharma professionals connect and stay abreast of the advancing technologies to drive improved patient outcomes. We help healthcare innovators engage their market to bring new technology into hospitals, clinics and offices to improve and streamline patient care.

Thanks for listening as we discuss technology and treatment trends ranging from clear aligner therapy all the way to MRI machines and lab automation equipment. If you enjoy what you hear, please like, subscribe and share.